| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |